Art
J-GLOBAL ID:201902212212443434   Reference number:19A2283305

Fasting Whole-Body Energy Homeostasis and Hepatic Energy Metabolism in Nondiabetic Humans with Fatty Liver

脂肪肝の非糖尿病性ヒトにおける絶食全身エネルギー恒常性と肝エネルギー代謝【JST・京大機械翻訳】
Author (11):
Material:
Volume: 2019  Page: Null  Publication year: 2019 
JST Material Number: U7012A  ISSN: 1942-0900  Document type: Article
Article type: 原著論文  Country of issue: United Kingdom (GBR)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Background. Fatty liver is bel...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2283305&from=J-GLOBAL&jstjournalNo=U7012A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (5):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for digestive system diseases  ,  Metabolic diseases,nutritional diseases in general.  ,  Digestive system diseases  ,  Liver  ,  Basic research of pharmacology of crude drugs 
Reference (30):
  • G. Marchesini, M. Brizi, A. M. Morselli-Labate, G. Bianchi, E. Bugianesi, A. J. McCullough, G. Forlani, N. Melchionda, "Association of nonalcoholic fatty liver disease with insulin resistance," The American Journal of Medicine, vol. 107, no. 5, pp. 450-455, 1999.
  • G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, R. Manini, S. Natale, E. Vanni, N. Villanova, N. Melchionda, M. Rizzetto, "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome," Hepatology, vol. 37, no. 4, pp. 917-923, 2003.
  • M. Roden, "Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance," Nature Clinical Practice Endocrinology & Metabolism, vol. 2, no. 6, pp. 335-348, 2006.
  • G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A. J. McCullough, S. Natale, G. Forlani, N. Melchionda, "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome," Diabetes, vol. 50, no. 8, pp. 1844-1850, 2001.
  • A. Gastaldelli, K. Cusi, M. Pettiti, J. Hardies, Y. Miyazaki, R. Berria, E. Buzzigoli, A. M. Sironi, E. Cersosimo, E. Ferrannini, R. A. DeFronzo, "Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects," Gastroenterology, vol. 133, no. 2, pp. 496-506, 2007.
more...

Return to Previous Page